Outset Medical Files DEF 14A Detailing Executive Compensation
Ticker: OM · Form: DEF 14A · Filed: Apr 11, 2025 · CIK: 1484612
| Field | Detail |
|---|---|
| Company | Outset Medical, INC. (OM) |
| Form Type | DEF 14A |
| Filed Date | Apr 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, DEF 14A, equity-awards
TL;DR
Outset Medical's DEF 14A is out, showing exec comp and equity award values for 2022-2024.
AI Summary
Outset Medical, Inc. filed a DEF 14A on April 11, 2025, for the fiscal year ending June 2, 2025. The filing details executive compensation and equity awards granted in prior years, with specific data points for 2022, 2023, and 2024. It includes information on the fair value of equity awards and changes in their value over time.
Why It Matters
This filing provides transparency into how Outset Medical compensates its top executives and the value of equity awards, which can influence investor decisions and employee morale.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the details on executive compensation and equity awards can sometimes reveal underlying company performance or strategic shifts.
Key Numbers
- 2022 — Year (Data reported for executive equity awards)
- 2023 — Year (Data reported for executive equity awards)
- 2024 — Year (Data reported for executive equity awards)
Key Players & Entities
- Outset Medical, Inc. (company) — Filer of the DEF 14A
- 20250411 (date) — Filing date
- 20250602 (date) — Fiscal year end
- 0000950170-25-053260 (filing_id) — Accession number for the filing
FAQ
What is the primary purpose of this DEF 14A filing for Outset Medical, Inc.?
The primary purpose is to provide detailed information regarding the company's annual meeting of stockholders, including executive compensation, director nominations, and other corporate governance matters.
When is the fiscal year end for which this filing is relevant?
The fiscal year end for which this filing is relevant is June 2, 2025.
What specific types of compensation data are detailed in the filing?
The filing details executive compensation, including information on equity awards granted, their fair value, and changes in fair value for the fiscal years 2022, 2023, and 2024.
What is the company's business address and phone number?
The company's business address is 3052 Orchard Drive, San Jose, CA 95134, and the business phone number is 669-231-8200.
What was Outset Medical's former company name and when did it change?
Outset Medical's former company name was Home Dialysis Plus, Ltd., and the name change occurred on February 19, 2010.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 11, 2025 regarding Outset Medical, Inc. (OM).